lactic acid has been researched along with enalapril in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Broqvist, M; Dahlström, U; Karlsson, E; Larsson, J | 1 |
| Imai, S; Ishihara, T; Nakazawa, M; Okuhira, M; Takahashi, Y | 1 |
| Haneda, T; Kikuchi, K; Takeda, H | 1 |
| Elisabetta, Z; Emanuela, M; Franzetti, I; Marco, G; Paolo, D; Renato, U | 1 |
| Blanchet, M; Curnier, D; De Champlain, J; Ducharme, A; Lamoureux, MC; Racine, N; Sheppard, R; Sirois, P; Tardif, JC; White, M | 1 |
2 trial(s) available for lactic acid and enalapril
| Article | Year |
|---|---|
Muscle energy metabolism in severe chronic congestive heart failure--effect of treatment with enalapril.
Topics: Adenosine Triphosphate; Aged; Aged, 80 and over; Biopsy; Double-Blind Method; Drug Therapy, Combination; Enalapril; Energy Metabolism; Exercise Test; Female; Furosemide; Glycogen; Heart Failure; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Middle Aged; Muscles; Phosphocreatine; Survival Rate | 1992 |
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Double-Blind Method; Drug Therapy, Combination; Enalapril; Exercise Tolerance; Female; Heart Failure; Humans; Irbesartan; Lactic Acid; Male; Middle Aged; Norepinephrine; Prospective Studies; Rest; Tetrazoles | 2005 |
4 other study(ies) available for lactic acid and enalapril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure.
Topics: Adenosine Triphosphate; Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Coronary Vessels; Disease Models, Animal; Dogs; Enalapril; Heart Failure; Lactates; Lactic Acid; Methoxamine; Microspheres; Myocardium; Oxygen Consumption; Phosphocreatine; Vascular Resistance; Ventricular Function, Left | 1993 |
Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
Topics: Adenine Nucleotides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Captopril; Coronary Circulation; Enalapril; Energy Metabolism; Heart Rate; Imidazoles; In Vitro Techniques; Lactic Acid; Losartan; Male; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 1997 |
Possible synergistic effect of metformin and enalapril on the development of hyperkaliemic lactic acidosis.
Topics: Acidosis; Aged; Antihypertensive Agents; Chlorides; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Hypoglycemic Agents; Lactic Acid; Metformin | 1997 |